Stephens Consulting’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$17.1K Buy
258
+8
+3% +$517 0.01% 210
2025
Q3
$16.8K Sell
250
-12
-5% -$950 0.01% 199
2025
Q2
$22.9K Buy
+262
New +$20.5K 0.01% 255
2022
Q1
Sell
-28
Closed -$3.76K 597
2021
Q4
$3.76K Buy
+28
New +$4.02K ﹤0.01% 540

Other funds holding DXCM

Stephens Consulting's DXCM Position: Q4 2025 in Review

Stephens Consulting increased its DexCom (DXCM) stake by 3.2% in Q4 2025, buying an estimated $517 and bringing the position to 258 shares worth $17.1K. The position accounts for 0.01% of the portfolio, ranked #210.

Stephens Consulting first reported a position in DXCM in Q4 2021 and has held it in 4 quarters since. The position peaked at $22.9K in Q2 2025. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Stephens Consulting held 258 shares of DexCom worth $17.1K as of Q4 2025.
  • Stephens Consulting bought 8 DexCom shares in Q4 2025, an estimated $517.
  • DexCom made up 0.01% of Stephens Consulting's portfolio in Q4 2025, its #210 holding.
  • Stephens Consulting first reported a position in DexCom in Q4 2021 and has held it in 4 quarters since.
  • Stephens Consulting's DexCom position peaked at $22.9K in Q2 2025.
  • 920 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Stephens Consulting's 13F filing for Q4 2025, filed 13 Jan 2026.